Bank Of America Corp Mustang Bio, Inc. Transaction History

Bank Of America Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.35 - $0.72 $505 - $1,039	1,444 Added 43.4%	4,771 $1,000
Q4 2022 Feb 10, 2023	BUY	$0.32 - $8.27 $41 - $1,075	130 Added 4.07%	3,327 $1,000
Q3 2022 Nov 14, 2022	SELL	$0.46 - $7.2 $6,328 - $99,057	-13,758 Reduced 81.14%	3,197 $1,000
Q2 2022 Aug 12, 2022	SELL	$0.58 - $1.13 $60 - $118	-105 Reduced 0.62%	16,955 $9,000
Q1 2022 May 16, 2022	SELL	$0.73 - $1.81 $21,241 - $52,667	-29,098 Reduced 63.04%	17,060 $17,000
Q4 2021 Feb 08, 2022	BUY	$1.66 - $2.64 $38,025 - $60,474	22,907 Added 98.52%	46,158 $77,000
Q3 2021 Nov 15, 2021	BUY	$2.58 - $3.36 $31,942 - $41,600	12,381 Added 113.9%	23,251 $62,000
Q2 2021 Sep 13, 2021	BUY	$2.7 - $3.81 $29,349 - $41,414	10,870 New	10,870 $35,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $27.4M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.